Involvement of intracellular calcium in morphine tolerance in mice

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 381-388

  Smith, Forrest L ^a   Dombrowski, Daniel S ^a   Dewey, William L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; Intracellular calcium; Morphine tolerance

Indexed keywords

EGTAZIC ACID; MORPHINE; NIFEDIPINE; OMEGA CONOTOXIN GVIA; RYANODINE; RYANODINE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG TOLERANCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; BIOLOGICAL TRANSPORT; CAFFEINE; CALCIUM; CALCIUM CHANNELS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; MALE; MICE; MICROSOMES; MORPHINE;

EID: 0032910370     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00168-3     Document Type: Article

References (60)

1. Antkiewicz-Michaluk L., Michaluk J., Romanska I., Vetulani J. Reduction in morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine. Psychopharmacology (Berlin). 111:1993;457-464.
2. ++ channels from brain microsomal membranes incorporated into planar lipid bilayers. J. Membr. Biol. 111:1989;179-189.
3. Aston-Jones G., Shipley M.T., Chouvet G., Ennis M., van Bockstaele E., Pieribone V., Shiekhattar R., Akaoka H., Drolet G., Astier B. Afferent regulation of locus coeruleus neurons. Anatomy, physiology and pharmacology Prog. Brain Res. 88:1991;47-75.
4. Baeyens J.M., Esposito E., Ossowski G., Samanin R. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur. J. Pharmacol. 137:1987;9-13.
5. Basilico L., Parolaro D., Rubino T., Gori E., Giagnoni G. Influence of omega-conotoxin on morphine analgesia and withdrawal syndrome in rats. Eur. J. Pharmacol. 218:1992;75-81.
6. ++ antagonists. Pharmacol. Res. Commun. 16:1984;1009-1018.
7. ++ antagonists on 6,7-benzomorphan-induced analgesia. Eur. J. Pharmacol. 90:1983;385-391.
8. ++ signalling. Nature. 361:1993;315-325.
9. Billman G.E. Intracellular calcium chelator, BAPTA-AM, prevents cocaine-induced ventricular fibrillation. Am. J. Physiol. 265:1993;H1529-H1535.
10. Bongianni F., Carla V., Moroni F., Pellegrini-Giampietro D.E. Calcium channels inhibitors suppress the morphine-withdrawal syndrome in rats. Br. J. Pharmacol. 88:1986;561-567.
11. ++ channel blockers in cardiac surgery. Eur. J. Anesth. 4:1987;387-394.
12. ++ mobilization in neuroblastoma X glioma NG108-15 cells. Mol. Pharmacol. 38:1990;282-288.
13. Carta F., Bianchi M., Argenton S., Cervi D., Marolla G., Tamburini M., Breda M., Fantoni A., Panerai A.E. Effect of nifedipine on morphine-induced analgesia. Anesth. Analg. 70:1990;493-498.
14. Chapman D.B., Way E.L. Metal ion interactions with opiates. Annu. Rev. Pharmacol. Toxicol. 20:1980;553-579.
15. Chapman D.B., Way E.L. Modification of endorphin/enkephalin analgesia and stress-induced analgesia by divalent cations, a cation chelator and an ionophore. Br. J. Pharmacol. 75:1982;389-396.
16. ++ and calmodulin. Biochemistry. 31:1992;6492-6498.
17. Colquhoun D. Lectures in biostatistics. An introduction to statistics with applications in biology and medicine:1971;Oxford Clarendon Press, London.
18. ++ channel antagonists increase morphine induced analgesia and antagonize morphine tolerance. Eur. J. Pharmacol. 148:1988;463-466.
19. D'Amour F.E., Smith D.L. A method of determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
20. Del Pozo E., Ruiz-Garcia C., Baeyens J.M. Analgesic effects of diltiazem and verapamil after central and peripheral administration in the hot-plate test. Gen. Pharamacol. 21:1990;681-685.
21. Dewey W.L., Harris L.S., Howes J.F., Nuite J.A. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther. 175:1970;435-442.
22. Dierssen M., Florez J., Hurle M.A. Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions. Naunyn Schmiedebergs Arch. Pharmacol. 342:1990;559-565.
23. 1 oscillations in bulfrog sympathetic neurons. Neuron. 8:1992;1109-1125.
24. ++. Life Sci. 31:1982;1237-1240.
25. ++ ion in the morphine analgesia. Jpn. J. Pharmacol. 14:1964;227-229.
26. Harris R.A., Loh H.H., Way E.L. Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance. J. Pharmacol. Exp. Ther. 195:1975;488-498.
27. Harris L.S., Pierson A.K. Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther. 143:1964;141-148.
28. ++ localization during the development of morphine tolerance and dependence. Kosterlitz H.W. Opiates and endogenous opioid peptides. 1976;361-368 Elsevier, New York.
29. ++ agonists and antagonists of the dihydropyridine type. Antinociceptive effects, interference with opiate μ-receptor agonists and neuropharmacological actions in rodents Psychopharmacology (Berlin). 90:1986;299-307.
30. Horvath G., Benedek G., Szikszay M. Enhancement of fentanyl analgesia by clonidine plus verapamil in rats. Anesth. Analg. 70:1990;284-288.
31. h in reconstitution systems. J. Biol. Chem. 267:1992;8887-8894.
32. ++ ATPase activity with rise and fall of morphine tolerance and dependence. Jpn. J. Pharmacol. 24:1974;123-129.
33. Kamiya H., Satsuki S., Yamamoto C. Synthetic omega-conotoxin blocks synaptic transmission in the hippocampus in vitro. Neurosci. Lett. 91:1988;84-88.
34. Koyano K., Abe T., Nishiuchi Y., Sakakibara S. Effects of synthetic omega-conotoxin on synaptic transmission. Eur. J. Pharmacol. 135:1987;337-343.
35. Marengo J.J., Bull R., Hidalgo C. Calcium dependence of ryanodine-sensitive calcium channels from brain cortex endoplasmic reticulum. FEBS Lett. 383:1996;59-62.
36. 3H-ryanodine receptor from rabbit brain membranes. J. Biol. Chem. 265:1990;18454-18460.
37. ++ release channel Neuron. 7:1991;17-25.
38. Patrick G.A., Dewey W.L., Spaulding T.C., Harris L.S. Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet-implanted mice. J. Pharmacol. Exp. Ther. 193:1975;876-883.
39. Pedigo N.W., Dewey W.L., Harris L.S. Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J. Pharmacol. Exp. Ther. 193:1975;845-852.
40. Pereira I.T., Prado W.A., Dos Reis M.P. Enhancement of the epidural morphine-induced analgesia by systemic nifedipine. Pain. 53:1993;341-355.
41. Pressman B.C. Biological applications of ionophores. Annu. Rev. Biochem. 45:1976;501-530.
42. 3H]-nitrendipine binding sites in the brain in morphine tolerant mice. Eur. J. Pharmacol. 102:1984;371-372.
43. Ramkumar V., El-Fakahany E.E. Prolonged morphine treatment increases rat brain dihydropyridine binding sites. Possible involvement in development of morphine dependence Eur. J. Pharmacol. 146:1988;73-83.
44. Reyes M., Stanton P.K. Induction of hippocampal long-term depression requires release of calcium from separate presynaptic and postsynaptic intracellular stores. J. Neurosci. 16:1996;5951-5960.
45. Reichling D.B., Kwiat G.C., Basbaum A.I. Anatomy, physiology and pharmacology of the periaquiductal gray contribution to antinociceptive controls. Fields H.L., Besson J.M. Progress in brain research, vol. 77. 1988;31-46 Elsevier Science Publishers B.V. (Biomedical Division), New York.
46. Roerig S.C., Fujimoto J.M. Morphine antinociception in different strains of mice. Relationship of supraspinal-spinal multiplicative interaction to tolerance J. Pharmacol. Exp. Ther. 247:1988;603-608.
47. ++ release channel. Am. J. Physiol. 253:1987;C364-C368.
48. 3H]-nitrendipine binding following chronic treatment with morphine. Neurochem. Int. 7:1985;1033-1036.
49. Santillan R., Maestre J.M., Hurle M.A., Florez J. Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine. A preliminary report Pain. 58:1994;129-132.
50. ++ channel blockade by certain opioids. Fundam. Appl. Toxicol. 3:1983;536-542.
51. Shmigol A., Verkhratsky A., Isenberg G. Calcium-induced calcium release in rat sensory neurons. J. Physiol. 489:1995;627-636.
52. Silverstone P.H., Done C., Sharp T. Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated withdrawal. An in vivo microdialysis study in the rat Psychopharmacology (Berlin). 109:1992;235-238.
53. Simpson P.B., Nahorski S.R., Challiss R.A.J. Agonist-evoked calcium mobilization from stores expressing inositol 1,4,5,-trisphosphate receptors and ryanodine receptors in cerebellar granule neurones. J. Neurochem. 67:1996;364-373.
54. Smith F.L., Stevens D.L. Calcium modulation of morphine analgesia. Role of calcium channels and intracellular pool calcium J. Pharmacol. Exp. Ther. 272:1995;290-299.
55. Tallarida R.J., Murray R.B. Manual of pharmacologic calculations with computer programs. 2:1987;Springer Verlag, New York. 26-44.
56. Vaupel D.B., Lange W.R., London E.D. Effects of verapamil on morphine-induced euphoria, analgesia and respiratory depression in humans. J. Pharmacol. Exp. Ther. 267:1993;1386-1394.
57. Vocci F.J., Welch S.P., Dewey W.L. Differential effects of divalent cations, cation chelators and ionophores on morphine and dibutyryl guanosine 3′, 5′-cyclic monophosphate antinociception. J. Pharmacol. Exp. Ther. 214:1980;463-466.
58. ++ in synaptosomes. Life Sci. 48:1991;1853-1861.
59. Yamamoto H., McCain H.W., Izumi K., Misawa S., Way E.L. Effects of amino acids, especially taurine and gamma-aminobutyric acid (GABA), on analgesia and calcium depletion induced by morphine in mice. Eur. J. Pharmacol. 71:1981;177-184.
60. ++ in the analgesia induced by buprenorphine. Metal Ions Biol. Med. 2:1992;340-342.